UCB - 1H - Technical analysis published on 09/26/2024 (GMT)
- 137
- 0
Click here for a new analysis!
- Timeframe : 1H
- - Analysis generated on
- Status : INVALID
Summary of the analysis
Additional analysis
Quotes
UCB rating 164.45 EUR. The price is lower by -2.46% since the last closing and was between 163.75 EUR and 169.20 EUR. This implies that the price is at +0.43% from its lowest and at -2.81% from its highest.So that you have an overall view of the price change, here is a table showing the variations over several periods:
New HIGH record (5 years)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1 year)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1st january)
Type : Bullish
Timeframe : Weekly
Near a new LOW record (1 month)
Type : Bearish
Timeframe : Weekly
Technical
Technical analysis of UCB in 1H shows an overall bullish trend. 64.29% of the signals given by moving averages are bullish. Caution: the neutral signals currently given by short-term moving averages show us that the global trend is losing momentum. The Central Indicators market scanner is currently detecting several bearish signals that could impact this trend:
Bearish trend reversal : adaptative moving average 20
Type : Bearish
Timeframe : 1 hour
Bearish trend reversal : adaptative moving average 50
Type : Bearish
Timeframe : 1 hour
In fact, 10 technical indicators on 18 studied are currently bearish. The Central Indicators scanner found no further results concerning independent technical indicators.
Central Patterns, the market scanner focusing on chart patterns, resistances and supports found these results:
Near horizontal support
Type : Bullish
Timeframe : 1 hour
Support of channel is broken
Type : Bearish
Timeframe : 1 hour
For a small rebound in the very short term, the Central Candlesticks scanner currently notes the presence of these bullish patterns in Japanese candlesticks:
Bullish harami
Type : Bullish
Timeframe : 1 hour
Bullish harami cross
Type : Bullish
Timeframe : 1 hour
S3 | S2 | S1 | Price | R1 | R2 | |
---|---|---|---|---|---|---|
ProTrendLines | 158.81 | 160.96 | 163.08 | 164.45 | 167.21 | 169.35 |
Change (%) | -3.43% | -2.12% | -0.83% | - | +1.68% | +2.98% |
Change | -5.64 | -3.49 | -1.37 | - | +2.76 | +4.90 |
Level | Major | Minor | Minor | - | Minor | Intermediate |
Attention could also be paid to pivot points to set price objectives:
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 163.10 | 164.30 | 166.45 | 167.65 | 169.80 | 171.00 | 173.15 |
Camarilla | 167.68 | 167.99 | 168.29 | 168.60 | 168.91 | 169.21 | 169.52 |
Woodie | 163.58 | 164.54 | 166.93 | 167.89 | 170.28 | 171.24 | 173.63 |
Fibonacci | 164.30 | 165.58 | 166.37 | 167.65 | 168.93 | 169.72 | 171.00 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 149.28 | 153.77 | 158.23 | 162.72 | 167.18 | 171.67 | 176.13 |
Camarilla | 160.24 | 161.06 | 161.88 | 162.70 | 163.52 | 164.34 | 165.16 |
Woodie | 149.28 | 153.76 | 158.23 | 162.71 | 167.18 | 171.66 | 176.13 |
Fibonacci | 153.77 | 157.19 | 159.30 | 162.72 | 166.14 | 168.25 | 171.67 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 124.22 | 132.93 | 148.32 | 157.03 | 172.42 | 181.13 | 196.52 |
Camarilla | 157.07 | 159.28 | 161.49 | 163.70 | 165.91 | 168.12 | 170.33 |
Woodie | 127.55 | 134.60 | 151.65 | 158.70 | 175.75 | 182.80 | 199.85 |
Fibonacci | 132.93 | 142.14 | 147.83 | 157.03 | 166.24 | 171.93 | 181.13 |
Numerical data
The following is the status of technical indicators and moving averages registered at the time this technical analysis was created:
RSI (14): | 43.51 | |
MACD (12,26,9): | 0.6700 | |
Directional Movement: | -5.11 | |
AROON (14): | -92.86 | |
DEMA (21): | 167.92 | |
Parabolic SAR (0,02-0,02-0,2): | 169.24 | |
Elder Ray (13): | -0.31 | |
Super Trend (3,10): | 163.74 | |
Zig ZAG (10): | 164.15 | |
VORTEX (21): | 0.9500 | |
Stochastique (14,3,5): | 33.66 | |
TEMA (21): | 167.88 | |
Williams %R (14): | -88.39 | |
Chande Momentum Oscillator (20): | -1.80 | |
Repulse (5,40,3): | -1.8900 | |
ROCnROLL: | -1 | |
TRIX (15,9): | 0.1200 | |
Courbe Coppock: | 1.25 |
MA7: | 163.81 | |
MA20: | 162.71 | |
MA50: | 157.57 | |
MA100: | 145.77 | |
MAexp7: | 166.46 | |
MAexp20: | 166.29 | |
MAexp50: | 164.72 | |
MAexp100: | 163.47 | |
Price / MA7: | +0.39% | |
Price / MA20: | +1.07% | |
Price / MA50: | +4.37% | |
Price / MA100: | +12.81% | |
Price / MAexp7: | -1.21% | |
Price / MAexp20: | -1.11% | |
Price / MAexp50: | -0.16% | |
Price / MAexp100: | +0.60% |
News
Don't forget to follow the news on UCB. At the time of publication of this analysis, the latest news was as follows:
- UCB Presents New 4-year Data for BIMZELX® (bimekizumab-bkzx) in Moderate-to-Severe Plaque Psoriasis at EADV 2024
- UCB Announces U.S. FDA Approvals for BIMZELX® (bimekizumab-bkzx) for the Treatment of Psoriatic Arthritis, Non-Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis
- UCB Elevates Hidradenitis Suppurativa Awareness with Inaugural Patient and HCP Summit with Special Appearance by Dr. Sandra Lee (AKA "Dr. Pimple Popper")
- UCB partners with Emmy Award winner Ben Decter and Tony Award nominee Kristin Hanggi in their heartfelt musical about living with epilepsy: It's All Your Fault, Tyler Price!
- FINTEPLA® (fenfluramine) Results Examining its Impact in Managing Generalized Tonic-Clonic Seizures in Developmental and Epileptic Encephalopathies Published in Epilepsia
Add a comment
Comments
0 comments on the analysis UCB - 1H